Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preference for Monthly Ibandronate vs Weekly Risedronate in Korean Women with Postmenopausal Osteoporosis
NCT00405392Phase 4Completed
- Sponsor
- GSK
- Start
- Mar 2007
- Primary completion
- May 2008
- Modality
- Small Molecules
01
Overview
A Phase 4 trial of ibandronate in postmenopausal osteoporosis, sponsored by GSK. Started Mar 2007; status: completed.
02
Drugs
ibandronate
03
Conditions
postmenopausal osteoporosis
Beyond the preview
Go deeper on NCT00405392.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT00405392.